Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Citalopram for social phobia: A clinical case series
Autore:
Simon, NM; Sharma, SG; Worthington, JJ; Marzol, PC; Pollack, MH;
Indirizzi:
Massachusetts Gen Hosp, Anxiety Disorders Program, Boston, MA 02114 USA Massachusetts Gen Hosp Boston MA USA 02114 Program, Boston, MA 02114 USA
Titolo Testata:
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
fascicolo: 7, volume: 25, anno: 2001,
pagine: 1469 - 1474
SICI:
0278-5846(200110)25:7<1469:CFSPAC>2.0.ZU;2-Q
Fonte:
ISI
Lingua:
ENG
Soggetto:
ANXIETY DISORDER;
Keywords:
citalopram; social anxiety; social phobia;
Tipo documento:
Review
Natura:
Periodico
Settore Disciplinare:
Life Sciences
Citazioni:
17
Recensione:
Indirizzi per estratti:
Indirizzo: Simon, NM Massachusetts Gen Hosp, Anxiety Disorders Program, 15 Parkman St,WAC 815, Boston, MA 02114 USA Massachusetts Gen Hosp 15 Parkman St,WAC 815Boston MA USA 02114
Citazione:
N.M. Simon et al., "Citalopram for social phobia: A clinical case series", PROG NEUR-P, 25(7), 2001, pp. 1469-1474

Abstract

1. Social anxiety disorder is a common illness with significant associateddisability. Serotonin selective reuptake inhibitors (SSRIs) have become first-line treatment given their improved tolerability; however, there are few reports on the use of citalopram.2. Nine consecutive patients with a primary diagnosis of DSM-IV generalized social phobia were prospectively treated with citalopram.3. Citalopram was generally well-tolerated, and seven patients achieved responder status.4. This series of patients improved significantly on all measures. Resultssuggest that citalopram may be a safe and effective treatment for social anxiety disorder.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/09/20 alle ore 02:19:28